SURVYR

WRBY

Warby Parker Inc.
$24.43
−$0.64 (2.55%)Oct 28 close
Consumer DiscretionaryS&P 600 CompareTechnicals
-30%-12%+7%+26%+44%Oct 2025Oct 2026Apr 202652w high $31.0052w low $14.96
WRBYSPY
Wall St. Highest PT $35.00 (+43.3%) Wall St. Avg PT $31.00 (+26.9%)
$16$21$26$31$36POC $25Hi $35Avg $31
Underwater Drawdown %Max DD -32.9%Current -19.5%
0.0%-32.9%
Relative Strength vs SPY-0.3% vs SPYUnderperforming
+46%0%-46%
1W
−$1.20 (4.68%)
1M
−$0.23 (0.93%)
3M
−$1.60 (6.15%)
6M
+$2.96 (13.79%)
YTD
+$2.64 (12.12%)
1Y
+$3.30 (15.62%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
13 analysts · mean score 1.62
1 = Strong Buy · 5 = Sell
Strong Buy215%
Buy862%
Hold323%
Underperform00%
Sell00%
Wall Street consensus
Analyst price targets
Current price$24.43
Average target$31.00
+$6.57 (+26.9%) upsideaverage target vs current price
CurrentAverageMedian
Low$25.00
Median$32.00
High$35.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-08-07 · UBS reiterated Neutral on WRBY
Reiterated
2026-08-07 · Citizens reiterated Market Outperform on WRBY
Initiated
2026-06-29 · B of A Securities started covering WRBY at Buy
Reiterated
2026-05-08 · UBS reiterated Neutral on WRBY
Reiterated
2026-05-07 · BTIG reiterated Buy on WRBY
Reiterated
2026-03-17 · Citigroup reiterated Neutral on WRBY

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$3.1B
P/E (last 12 months)417.8
P/E (next 12 months, estimated)40.8
52-week range$14.96 – $31.00
Revenue growth (latest quarter vs a year ago)+9.8%
Dividend yieldNo dividend
Analyst consensusBuy (12)
Average analyst price target$31.00 (+27%)

What they do

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray.

Healthcare · Medical Instruments & Supplies
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
92nd percentile in sector
A
12-1 return: +41.8%
Percentile within its GICS sector across the S&P 1500.
Growth
79th percentile in sector
B+
Revenue growth (YoY): +9.8%
Percentile within its GICS sector across the S&P 1500.
Value
2nd percentile in sector
F
Forward E/P: 2.6% · EBITDA/EV: 1.5%
Percentile within its GICS sector across the S&P 1500.
Profitability
11th percentile in sector
D-
Profit margin: +0.8% · Return on equity: +2.1%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
SURVYR. Long Book
Not in the current book

Earnings & events

WRBY earningsNext report in 7 days
Next report · quarter Sep 2026
Thu Nov 5, 2026Before the open
EPS consensus$0.09 range $0.08–$0.12
Revenue consensus$245.1M 13 analysts
Last 4 quarters · EPS vs estimate
Aug 6, 2026$0.15est $0.11+30.0%Above estimates
May 7, 2026$0.11est $0.11+3.8%In line with estimates
Feb 26, 2026$0.02est $0.05−58.3%Below estimates
Nov 6, 2025$0.12est $0.09+38.1%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:04:40 ET
24-1125-0225-0525-0825-1126-0226-0526-080.000.15
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$235.5M+9.8%
2026-03-31$242.4M–
2025-12-31$212.0M–
2025-09-30$221.7M–
2025-06-30$214.5M–

News & catalysts

More news
Samsung’s AI glasses make a bold bet against Meta
TheStreet · Oct 15
Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
Business Wire · Oct 15
Tractor Supply, Warby Parker, and Sportsman's Warehouse Stocks Trade Down, What You Need To Know
StockStory · Oct 14
3 Cash-Producing Stocks with Warning Signs
StockStory · Oct 14
Brands Say They’re Pouring Tariff Refunds Into Marketing
The Wall Street Journal · Oct 09
Rating changes
Reiterated
2026-08-07 · UBS reiterated Neutral on WRBY
Reiterated
2026-08-07 · Citizens reiterated Market Outperform on WRBY
Initiated
2026-06-29 · B of A Securities started covering WRBY at Buy
Reiterated
2026-05-08 · UBS reiterated Neutral on WRBY
Reiterated
2026-05-07 · BTIG reiterated Buy on WRBY
Reiterated
2026-03-17 · Citigroup reiterated Neutral on WRBY

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Blumenthal Neil Harris
Director, Co-Chief Executive Officer · 2026-10-01
Sell
$2.8M
Raider Jeffrey Jacob
Director · 2026-10-01
Sell
$415.5K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:04:40 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026